Personal information

Verified email domains

Activities

Employment (5)

The Ohio State University: Columbus, Ohio, US

2022-09-12 to present | Post-doctoral Scholar (Ophthalmology & Visual Sciences )
Employment
Source: Self-asserted source
Abdelrahman M. Elsayed

Al-Azhar University Faculty of Pharmacy: Cairo, EG

2016-04-20 to present | Assistant Lecturer (Pharmacology & Toxicology)
Employment
Source: Self-asserted source
Abdelrahman M. Elsayed

Al Azhar University: Cairo, EG

2021-09-06 to 2022-09-10 | Lecturer (Pharmacology & Toxicology)
Employment
Source: Self-asserted source
Abdelrahman M. Elsayed

The University of Texas MD Anderson Cancer Center: Houston, TX, US

2018-11-19 to 2021-02-26 | Graduate non UTHS (Experimental Therapeutics)
Employment
Source: Self-asserted source
Abdelrahman M. Elsayed

Al-Azhar University Faculty of Pharmacy: Cairo, EG

2012-04-12 to 2016-04-19 | Demonstrator (Pharmacology & Toxicology)
Employment
Source: Self-asserted source
Abdelrahman M. Elsayed

Education and qualifications (3)

Al-Azhar University Faculty of Pharmacy: Cairo, EG

2016-04-20 to 2021-09-05 | PhD (Pharmacology & Toxicology )
Education
Source: Self-asserted source
Abdelrahman M. Elsayed

Al Azhar University Faculty of Pharmacy: Cairo, EG

2013 to 2016 | M.Sc. (Pharmacology & Toxicology )
Qualification
Source: Self-asserted source
Abdelrahman M. Elsayed

Al Azhar University Faculty of Pharmacy: Cairo, EG

2004 to 2009 | B.Sc. (Faculty of Pharmacy)
Qualification
Source: Self-asserted source
Abdelrahman M. Elsayed

Works (11)

An overview of BAP1 biological functions and current therapeutics

Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
2025-01 | Journal article
Part of ISSN: 0304-419X
Contributors: Abdelrahman M. Elsayed; Muaiad Kittaneh; Colleen M. Cebulla; Mohamed H. Abdel-Rahman
Source: Self-asserted source
Abdelrahman M. Elsayed

Liraglutide mitigates dexamethasone-induced fatty acid synthase (FASN) and the cluster of differentiation36 (CD36) expression: a potential treatment for glucocorticoid-induced non-alcoholic fatty liver disease (NAFLD)

Naunyn-Schmiedeberg's Archives of Pharmacology
2025-01-17 | Journal article
Part of ISSN: 0028-1298
Part of ISSN: 1432-1912
Contributors: Dahshan Hassan Selim; Hamada Ahmed Mokhlis; Abdelrahman M. Elsayed; Abdel-Aziz S. Shatat; Salama Abdou Salama; Raed Shahat Ismail
Source: Self-asserted source
Abdelrahman M. Elsayed

Somatic mutations in uveal melanomas impact the disease response to radiation

Cancer Biology Research Program Retreat
2024-06-20 | Conference poster | Data curation
Contributors: Abdelrahman M. Elsayed; Mohamed H. Abdel-rahman
Source: Self-asserted source
Abdelrahman M. Elsayed

Abstract 4742: Targeting the RNA-binding protein LARP1 overcomes therapeutic resistance in ovarian cancer

Cancer Research
2024-03-22 | Journal article
Part of ISSN: 1538-7445
Contributors: Abdelrahman M. Elsayed; Paola Amero; Emine Bayraktar; Anil K. Sood; Gabriel Lopez-Berestein; Cristian Rodriguez-Aguayo
Source: Self-asserted source
Abdelrahman M. Elsayed

An Overview of the Immune Modulatory Properties of Long Non-Coding RNAs and Their Potential Use as Therapeutic Targets in Cancer

Non-Coding RNA
2023-11-11 | Journal article
Contributors: Moises Martinez-Castillo; Abdelrahman M. Elsayed; Gabriel López-Berestein; Paola Amero; Cristian Rodríguez-Aguayo
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Targeting CDK7 reverses tamoxifen resistance through regulating stemness in ER+ breast cancer.

Pharmacological reports : PR
2022-01-09 | Journal article
Source: Self-asserted source
Abdelrahman M. Elsayed

Conversion of RNA Aptamer into Modified DNA Aptamers Provides for Prolonged Stability and Enhanced Antitumor Activity.

Journal of the American Chemical Society
2021-05-14 | Journal article
Source: Self-asserted source
Abdelrahman M. Elsayed
grade
Preferred source (of 2)‎

PRKAR1B-AS2 Long Noncoding RNA Promotes Tumorigenesis, Survival, and Chemoresistance via the PI3K/AKT/mTOR Pathway.

International journal of molecular sciences
2021-02-13 | Journal article
Source: Self-asserted source
Abdelrahman M. Elsayed

Back to the Future: Rethinking the Great Potential of lncRNA<sub>S</sub> for Optimizing Chemotherapeutic Response in Ovarian Cancer.

Cancers
2020-08-25 | Journal article
Source: Self-asserted source
Abdelrahman M. Elsayed

Blockade of CDK7 Reverses Endocrine Therapy Resistance in Breast Cancer.

International journal of molecular sciences
2020-04-23 | Journal article
Source: Self-asserted source
Abdelrahman M. Elsayed

All-trans retinoic acid potentiates cisplatin-induced kidney injury in rats: impact of retinoic acid signaling pathway.

Naunyn-Schmiedeberg's archives of pharmacology
2015-12-11 | Journal article
Source: Self-asserted source
Abdelrahman M. Elsayed